Search

Search Constraints

You searched for: Author/Creator Chowers, Y

Search Results

1. DOP39 Utilization and sustainability of biologics in UC - A nationwide study from the epi-IIRN. (27th May 2021)

2. DOP45 Utilization and sustainability of biologics in CD - A nationwide study from the epi-IIRN. (27th May 2021)

3. DOP62 Efficacy of biologic drugs in short-duration versus long-duration Inflammatory Bowel Disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials. (21st January 2022)

4. DOP73 Antibiotic use differentially affects the risk of antidrug antibody formation during anti-TNFα therapy in Inflammatory Bowel Disease. (27th May 2021)

6. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. (15th February 2006)

8. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. (July 2022)

9. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. (14th July 2015)

10. P082 A cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of IBD patients. (16th January 2018)